Nrf2 pathway in patients with Parkinson’s disease
Objective: To demonstrate the activation of Nuclear factor erythroid-2-related factor 2 (Nrf2) pathway in PD patients. Background: Experimental data indicated the critical involvement of Nrf2…Measuring perceived-health status in Parkinson’s Disease – the role of London Handicap Scale
Objective: To characterize the handicap of a broad sample of PD patients. Background: Measuring perceived-health status has an important role in Parkinson’s Disease (PD) to…Harmonics: A reliable marker in tremor analysis for the differential diagnosis of Parkinson’s disease and multiple system atrophy
Objective: We aim to develop a reliable and convenient marker derived from the tremor characteristics to identify the two conditions. Background: The early-stage identification between…Impact of quantitative assessment of parkinsonian symptoms using wearable technology on treatment decisions
Objective: We evaluated the impact on routine treatment decisions of using the Parkinson’s KinetiGraph(PKG) to provide objective patient information Background: Continuous objective measurements using wearable technology may…Alpha-synuclein expression and cytokine profile in blood of patients with Lewy body dementias
Objective: To examine alpha-synuclein expression in CD45+ and cytokine levels in blood of patients with dementia with Lewy bodies (DLB), Parkinson's disease dementia (PDD). Background:…131-MIBG is less promising in differentiating Parkinson’s disease from other parkinsonism for early onset patients
Objective: To investigate the diagnostic value of 131I-MIBG cardiac scintigraphy in differentiating PD from other parkinsonism for distinct age of onset. Background: MIBG cardiac sympathetic imaging has…Characteristics and correlative factors of autonomic dysfunction in Chinese Parkinson’s disease
Objective: To study the clinical features and correlative factors of AutD in Chinese PD. Background: Autonomic dysfunction (AutD), which is defined as dysfunction of the…New Neuropathological Staging System for Lewy Body Disease
Objective: Present the validation of the new proposed novel staging system (NSS) for Lewy body disease and compare it against the previously proposed staging systems. Background:…Development and Validation of the Parkinson’s Disease Medication Adherence Scale (PD- MAS)
Objective: To develop and validate the PD-MAS. Background: Parkinson's disease (PD) is a neurodegenerative disease manifested by motor and non-motor symptoms, controlled with drug, neurosurgical…High-Beta and High-Gamma Power Oscillations from Subthalamic Nucleus distinguishes Parkinson’s Disease Subtypes
Objective: To distinguish Parkinson’s disease (PD) subtypes – tremor dominant (TD) and Akinetic-rigid (AR) – by means of local field potentials spectral features recorded from…
- « Previous Page
- 1
- …
- 182
- 183
- 184
- 185
- 186
- …
- 217
- Next Page »